Literature DB >> 30914385

Modulation of midbrain neurocircuitry by intranasal insulin.

Sharmili Edwin Thanarajah1, Sandra Iglesias2, Bojana Kuzmanovic3, Lionel Rigoux3, Klaas E Stephan4, Jens C Brüning5, Marc Tittgemeyer6.   

Abstract

Insulin modulates dopamine neuron activity in midbrain and affects processes underlying food intake behaviour, including impulsivity and reward processing. Here, we used intranasal administration and task-free functional MRI in humans to assess time- and dose-dependent effects of insulin on functional connectivity of the dopaminergic midbrain - and how these effects varied depending on systemic insulin sensitivity as measured by HOMA-IR. Specifically, we used a repeated-measures design with factors dose (placebo, 40 IU, 100 IU, 160 IU), time (7 time points during a 90 min post-intervention interval), and group (low vs. high HOMA-IR). A factorial analysis identified a three-way interaction (with whole-brain significance) with regard to functional connectivity between midbrain and the ventromedial prefrontal cortex. This interaction demonstrates that systemic insulin sensitivity modulates the temporal course and dose-dependent effects of intranasal insulin on midbrain functional connectivity. It suggests that altered insulin sensitivity may impact on dopaminergic projections of the midbrain and might underlie the dysregulation of reward-related and motivational behaviour in obesity and diabetes. Perhaps most importantly, the time courses of midbrain functional connectivity we present may provide useful guidance for the design of future human studies that utilize intranasal insulin administration.
Copyright © 2019 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30914385     DOI: 10.1016/j.neuroimage.2019.03.050

Source DB:  PubMed          Journal:  Neuroimage        ISSN: 1053-8119            Impact factor:   6.556


  11 in total

1.  Empagliflozin Improves Insulin Sensitivity of the Hypothalamus in Humans With Prediabetes: A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Trial.

Authors:  Stephanie Kullmann; Julia Hummel; Robert Wagner; Corinna Dannecker; Andreas Vosseler; Louise Fritsche; Ralf Veit; Konstantinos Kantartzis; Jürgen Machann; Andreas L Birkenfeld; Norbert Stefan; Hans-Ulrich Häring; Andreas Peter; Hubert Preissl; Andreas Fritsche; Martin Heni
Journal:  Diabetes Care       Date:  2022-02-01       Impact factor: 19.112

Review 2.  Intranasal Delivery: Effects on the Neuroimmune Axes and Treatment of Neuroinflammation.

Authors:  Elizabeth M Rhea; Aric F Logsdon; William A Banks; Michelle E Erickson
Journal:  Pharmaceutics       Date:  2020-11-20       Impact factor: 6.321

Review 3.  Brain insulin signalling in metabolic homeostasis and disease.

Authors:  Thomas Scherer; Kenichi Sakamoto; Christoph Buettner
Journal:  Nat Rev Endocrinol       Date:  2021-06-09       Impact factor: 43.330

Review 4.  Regulation of Metabolic Health by an "Olfactory-Hypothalamic Axis" and Its Possible Implications for the Development of Therapeutic Approaches for Obesity and T2D.

Authors:  Mara Alaide Guzmán-Ruiz; Adriana Jiménez; Alfredo Cárdenas-Rivera; Natalí N Guerrero-Vargas; Diana Organista-Juárez; Rosalinda Guevara-Guzmán
Journal:  Cell Mol Neurobiol       Date:  2021-04-04       Impact factor: 5.046

Review 5.  Obesity - A Matter of Motivation?

Authors:  Ruth Hanssen; Sharmili E Thanarajah; Marc Tittgemeyer; Jens C Brüning
Journal:  Exp Clin Endocrinol Diabetes       Date:  2022-02-18       Impact factor: 2.426

6.  The effect of intranasal insulin on appetite and mood in women with and without obesity: an experimental medicine study.

Authors:  Elizabeth Schneider; Maartje S Spetter; Elizabeth Martin; Elizabeth Sapey; Kay Por Yip; Konstantinos N Manolopoulos; Abd A Tahrani; Jason M Thomas; Michelle Lee; Manfred Hallschmid; Pia Rotshtein; Colin T Dourish; Suzanne Higgs
Journal:  Int J Obes (Lond)       Date:  2022-04-09       Impact factor: 5.551

7.  Effect of eating habits on obesity in adolescents: a study among Chinese college students.

Authors:  Qi Xie; Meng-Lei Hao; Ling-Bing Meng; Xiao-Qin Zuo; Peng Guo; Yong Qiu; Qiang Wang; Na Zhang; Min Lei
Journal:  J Int Med Res       Date:  2019-12-16       Impact factor: 1.671

8.  MemAID: Memory advancement with intranasal insulin vs. placebo in type 2 diabetes and control participants: a randomized clinical trial.

Authors:  Vera Novak; Christos S Mantzoros; Peter Novak; Regina McGlinchey; Weiying Dai; Vasileios Lioutas; Stephanie Buss; Catherine B Fortier; Faizan Khan; Laura Aponte Becerra; Long H Ngo
Journal:  J Neurol       Date:  2022-04-28       Impact factor: 6.682

9.  Safety of Intranasal Insulin in Type 2 Diabetes on Systemic Insulin: A Double-Blinded Placebo-Controlled Sub-Study of Memaid Trial.

Authors:  L Aponte Becerra; B Galindo Mendez; F Khan; V Lioutas; P Novak; C S Mantzoros; L H Ngo; V Novak
Journal:  Arch Diabetes Obes       Date:  2022-06-29

Review 10.  Intranasal Insulin: a Treatment Strategy for Addiction.

Authors:  Bhavani Kashyap; Leah R Hanson; William H Frey Ii
Journal:  Neurotherapeutics       Date:  2020-01       Impact factor: 7.620

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.